CARVEDILOL

Wed Jun 04 2025

View source

- views

Reason for Recall

CGMP Deviations; presence 'N-Nitroso Carvedilol I' Impurity above the recommended acceptable intake limit

Manufacturers

Drug	Manufacturer
CARVEDILOL	Glenmark Pharmaceuticals Inc., USA

Number of affected units

84,048 bottles

Distribution pattern

U.S. Nationwide

UPCs

Info not provided.

Package NDCs

NDC
68462-162-60
68462-162-01
68462-162-18
68462-162-05
68462-162-10
68462-163-60
68462-163-01
68462-163-18
68462-163-05
68462-163-10
68462-164-60
68462-164-01
68462-164-18
68462-164-05
68462-164-10
68462-165-60
68462-165-01
68462-165-18
68462-165-05
68462-165-10

0 views